Also of note in Parkinson’s patients is gastrointestinal dysfunction, leading to a revelation that the gut–brain axis contributes to pathology both via direct alpha-synuclein trafficking, as well as interactions with gut microbiota (224). This evidence concerns the gene SNCA and Parkinson disease.